Subscribe to Neurology
View Sample

FREE Email Newsletter

External Trigeminal Nerve Stimulation (eTNS) For Refractory Status Epilepticus

March 25, 2013 3:17 pm | by Bio-Medicine.Org | News | Comments

LOS ANGELES , March 25, 2013 /- NeuroSigma, Inc., a California -based medical device company, today announced that it will exhibit its CE Mark approved, non-invasive Monarch™ eTNS™ System for the adjunctive treatment of epilepsy and depression, at the 4th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures to be held in Salzburg, Austria...

Nerve Mapping Tech Improves Surgery for Compressed Nerves

March 25, 2013 1:41 pm | by Henry Ford Health System | News | Comments

Nerve mapping technology allows surgeons to determine whether surgery has been effective for relieving pressure from compressed nerves, which often function poorly and cause sciatica or pain and weakness in muscles supplied by the nerve.

Low-Cost ‘Cooling Cure’ Could Avert Brain Damage in Oxygen-Starved Babies

March 25, 2013 12:08 pm | by Johns Hopkins University | News | Comments

When babies are deprived of oxygen before birth, brain damage and disorders such as cerebral palsy can occur. Extended cooling can prevent brain injuries, but this treatment is not always available in developing nations where advanced medical care is scarce.


Vycor Issued Hong Kong Patent for Its VBAS Minimally Invasive Brain Access System

March 25, 2013 8:30 am | by The Associated Press | News | Comments

Vycor Medical, Inc., a provider of innovative and superior surgical and therapeutic solutions, announced it has been issued patent number 10106385.8 for its ViewSite™ Brain Access System ("VBAS") for the Hong Kong market. Vycor has a distribution agreement in place with Devon Medical which covers Hong Kong and China.

Alcyone Lifesciences and DNAtrix, Inc. to Collaborate on Unique Delivery System to Treat Brain Tumors

March 20, 2013 2:33 pm | by The Associated Press | News | Comments

Alcyone Lifesciences, Inc., a privately held biopharmaceutical medical device company focusing on developing products for the treatment of difficult neuropathological conditions, and DNAtrix, Inc., a privately held biotechnology company developing virus-based immunotherapy...

International Stem Cell Corporation Announces Positive Stem Cell Data in Parkinson's Disease

March 20, 2013 8:00 am | by The Associated Press | News | Comments

International Stem Cell Corporation, a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells today announced positive results demonstrating the safety and efficacy of stem cell...

International Stem Cell Corporation Announces Positive Results of Primate Parkinson's Study

March 19, 2013 8:00 am | by The Associated Press | News | Comments

International Stem Cell Corporation, a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells, announced today safety and encouraging efficacy of stem cell therapy in rodent and non-human primate models of Parkinson's disease.

Athena Diagnostics Announces New Genetic Testing Services for Rare Neurological Disorders

March 18, 2013 1:07 pm | by Bio-Medicine.Org | News | Comments

Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available...


InspireMD Wins CE Mark for MGuard Blood Clot Stent

March 15, 2013 1:56 pm | by Mass Device | News | Comments

InspireMD said it won a nod from European regulators for its MGuard embolic protection stent, designed to prevent strokes after carotid artery stenting procedures. The company said the MGuard device is wrapped with its MicroNet mesh to prevent embolisms – blood clots – from occurring during and after the placement of a carotid stent.

MRI Scans Reveal Distinct Brain Injuries After Concussion

March 14, 2013 3:35 pm | by Massachusetts Institute of Technology | News | Comments

Brain scans may be able to detect two distinct kinds of brain injury in patients who have suffered a mild head injury or concussion, say researchers from the National Institute of Neurological Disorders and Stroke. Differentiating between the two may help doctors better treat patients.

Getting Stroke Patients Back on Their Feet with Robots

March 13, 2013 3:43 pm | by SINTEF | News | Comments

A robot is now being built to help stroke patients with training, motivation, and walking. In Europe, strokes are the most common cause of physical disability among the elderly. This often result in paralysis of one side of the body, and many patients suffer much reduced physical mobility and are often unable to walk on their own.

Data on ElectroCore's Vagal Nerve Stimulation Therapy GammaCore Selected for an Oral Presentation at the 65th American Academy of Neurology Annual Meeting

March 13, 2013 9:38 am | by PR Newswire | News | Comments

MORRIS PLAINS, N.J., March 13, 2013 /PRNewswire/ -- ElectroCore®, a company dedicated to developing effective, non-invasive Vagal Nerve Stimulation (nVNS) therapies for serious medical conditions including primary headaches, announced today that data demonstrating the efficacy...

NeuroMetrix Partners with Handok Pharmaceuticals for NC-stat DPNCheck Distribution in the Republic of Korea

March 12, 2013 7:00 am | by The Associated Press | News | Comments

WALTHAM, Mass.--(BUSINESS WIRE)--Mar 12, 2013--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that it has entered an agreement with Handok Pharmaceuticals, Inc. Under terms of the agreement,...


NFL's Goodell Hopes for Lighter Helmets, Sensors

March 11, 2013 6:38 pm | by HOWARD FENDRICH - AP Pro Football Writer - Associated Press | News | Comments

NFL Commissioner Roger Goodell imagines a day in the not-too-distant future when players could be checked to determine whether their genetic makeup leaves them more likely to develop brain disease. They then might be told to switch to a less dangerous position — or give up football entirely.

GE, NFL & Leading Healthcare Experts Team up to Accelerate Concussion Research, Diagnosis & Treatment

March 11, 2013 1:00 pm | by The Associated Press | News | Comments

NEW YORK--(BUSINESS WIRE)--Mar 11, 2013--(NYSE: GE) – GE and the NFL today announced the Head Health Initiative, a four-year, $60 million collaboration to speed diagnosis and improve treatment for mild traumatic brain injury. The goal of the research and innovation program, guided by healthcare...

A Wireless Brain-Computer Interface

March 11, 2013 12:00 am | by Massachusetts Institute of Technology | News | Comments

A new wireless brain implant could be an important step toward technology that lets people with mobility problems control a computer or wheelchair with their thoughts. The implant was developed by a team at Brown University in Providence, Rhode Island.

Boston Scientific Apologizes for Embargo Breach that Got Its Watchman Trial Pulled from Conference

March 9, 2013 11:16 pm | by Mass Device | News | Comments

American College of Cardiology conference organizers cancel the highly anticipated presentation of preliminary results from Boston Scientific's PREVAIL study after the company leaks the data ahead of time. Boston Scientific publishes the slides that would have been presented.

The Boston Scientific Watchman@ Device Continues To Demonstrate Positive Clinical Outcomes For Patients With Atrial Fibrillation

March 9, 2013 2:24 pm | by The Associated Press | News | Comments

Boston Scientific Corporation (NYSE: BSX) reports preliminary data in the PREVAIL clinical trial met two out of three co-primary endpoints. The PREVAIL trial evaluates safety and efficacy of the WATCHMAN@ Left Atrial Appendage (LAA) Closure device in patients with nonvalvular atrial...

Boston Scientific's Watchman Heart Implant Shows Improved Safety Profile in Preliminary Results

March 9, 2013 12:12 pm | by Mass Device | News | Comments

Boston Scientific hopes to reassure FDA regulators about the safety and efficacy of its Watchman stroke prevention implant with results from its PREVAIL study, the presentation for which was pulled from the lineup at the American College of Cardiology conference in San Francisco today.

DNA Sequencing Giant Illumina Joins Hunt for Autism Blood Test

March 8, 2013 4:37 pm | by Massachusetts Institute of Technology | News | Comments

Illumina will work with SynapDx’s to find a blood-test that could allow treatment to start earlier. Massachusetts startup SynapDx announced on Wednesday that it will work with DNA sequencer manufacturer Illumina  to develop early detection tools for autism spectrum disorders, according to a release.

Ad-Tech Brain Implant Recall Gets FDA's Highest-Risk Status

March 8, 2013 7:29 am | by Mass Device | News | Comments

Federal healthcare regulators gave Ad-Tech Medical Instrument Corp.'s wide-reaching brain implant recall Class I status, the highest-risk category for medical device recalls. Late last year the Wisconsin-based medical device maker recalled its Macro Micro Subdural Electrodes over concerns that the implanted devices could cause damage to the brain.

Breakthrough in Artificial Intelligence-Based Robotics Neurosurgery

March 7, 2013 2:37 pm | by Bio-Medicine.Org | News | Comments

Imaging and robotic technologies have the potential to help neurosurgeons perform precise, fast and more comprehensive testing of brain tissue during surgery, identification of cancer type, grade and tumor margins and help them navigate through the brain, according to Akash Singh , PhD. Akash Singh , PhD, performs his scientific...

The Brain Activity Map

March 7, 2013 2:26 pm | by Massachusetts Institute of Technology | News | Comments

Researchers explain the goals and structure of a new brain-mapping project. A proposed effort to map brain activity on a large scale, expected to be announced by the White House later this month, could help neuroscientists understand the origins of cognition, perception, and other phenomena.

Funding: Nevro Corp. Lands $48M in Support of Spinal Cord Stimulation Tech

March 7, 2013 1:12 pm | by Mass Device | News | Comments

Menlo Park, Calif.-based Nevro Corp. raised $48 million in a Series C financing round in support of its high-frequency spinal cord stimulation technology, including investments from Covidien Ventures and Johnson & Johnson Development Corp. Nevro develops and markets the Senza HF-SCS system for treatment of chronic pain and other disorders.

Study: Experimental Anorexia Treatment with Deep Brain Stimulation May Provide Lasting Results

March 7, 2013 8:59 am | by Mass Device | News | Comments

In what some are calling "a world 1st," researchers reported some success in treating severe anorexia patients via implanted electrodes that delivered electrical energy to the regions of the brain associated with emotion. The study enrolled 6 patients to receive the experimental treatment...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.